Literature DB >> 27858943

APOBEC3A intratumoral DNA electroporation in mice.

A Kostrzak1, V Caval2, M Escande1, E Pliquet1, J Thalmensi1, T Bestetti1, M Julithe1, L Fiette3,4, T Huet1, S Wain-Hobson1,2, P Langlade-Demoyen1,2.   

Abstract

Human APOBEC3A (A3A) cytidine deaminase shows pro-apoptotic properties resulting from hypermutation of genomic DNA, induction of double-stranded DNA breaks (DSBs) and G1 cell cycle arrest. Given this, we evaluated the antitumor efficacy of A3A by intratumoral electroporation of an A3A expression plasmid. DNA was repeatedly electroporated into B16OVA, B16Luc tumors of C57BL/6J mice as well as the aggressive fibrosarcoma Sarc2 tumor of HLA-A*0201/DRB1*0101 transgenic mice using noninvasive plate electrodes. Intratumoral electroporation of A3A plasmid DNA resulted in regression of ~50% of small B16OVA melanoma tumors that did not rebound in the following 2 months without treatment. Larger or more aggressive tumors escaped regression when so treated. As APOBEC3A was much less efficient in provoking hypermutation and DSBs in B16OVA cells compared with human or quail cells, it is likely that APOBEC3A would be more efficient in a human setting than in a mouse model.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27858943     DOI: 10.1038/gt.2016.77

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  50 in total

Review 1.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

2.  Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration.

Authors:  Pieranna Chiarella; Emanuela Massi; Mariangela De Robertis; Annarita Sibilio; Paola Parrella; Vito Michele Fazio; Emanuela Signori
Journal:  Expert Opin Biol Ther       Date:  2008-11       Impact factor: 4.388

Review 3.  Electroporation for drug and gene delivery in the clinic: doctors go electric.

Authors:  Julie Gehl
Journal:  Methods Mol Biol       Date:  2008

Review 4.  Combining immunotherapy and targeted therapies in cancer treatment.

Authors:  Matthew Vanneman; Glenn Dranoff
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

5.  A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.

Authors:  Vincent Caval; Rodolphe Suspène; Milana Shapira; Jean-Pierre Vartanian; Simon Wain-Hobson
Journal:  Nat Commun       Date:  2014-10-09       Impact factor: 14.919

6.  In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.

Authors:  T Kishida; H Asada; E Satoh; S Tanaka; M Shinya; H Hirai; M Iwai; H Tahara; J Imanishi; O Mazda
Journal:  Gene Ther       Date:  2001-08       Impact factor: 5.250

7.  IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.

Authors:  M Lee Lucas; Loree Heller; Domenico Coppola; Richard Heller
Journal:  Mol Ther       Date:  2002-06       Impact factor: 11.454

8.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

9.  Orthologous mammalian APOBEC3A cytidine deaminases hypermutate nuclear DNA.

Authors:  Vincent Caval; Rodolphe Suspène; Jean-Pierre Vartanian; Simon Wain-Hobson
Journal:  Mol Biol Evol       Date:  2013-10-25       Impact factor: 16.240

10.  Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

Authors:  Adil I Daud; Ronald C DeConti; Stephanie Andrews; Patricia Urbas; Adam I Riker; Vernon K Sondak; Pamela N Munster; Daniel M Sullivan; Kenneth E Ugen; Jane L Messina; Richard Heller
Journal:  J Clin Oncol       Date:  2008-11-24       Impact factor: 44.544

View more
  1 in total

1.  Electroporation outperforms in vivo-jetPEI for intratumoral DNA-based reporter gene transfer.

Authors:  Liesl Jacobs; Elien De Smidt; Nick Geukens; Paul Declerck; Kevin Hollevoet
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.